03622nam a2200409zi 45000010014000000030008000140050017000220070015000390080041000540200028000950200025001230220014001480400031001620720016001930720015002090720015002242450083002392640067003223360021003893370023004103380032004333650110004653660044005754900036006195000047006555050638007025160013013405200943013535450619022966500034029156500033029496500033029827000032030157000035030478560068030828560062031509781849841443UK-WkNB20210209000000.0cu||||||||||||210209e202201uuxxk |s|||||||0|0 eng|d a9781849841443 :c$85.00 a1849841446 :c$85.00 a2312-5098 aUK-WkNBbengcUK-WkNBerda 7aMJL2bicssc 7aHEA2ukslc 7aMJL2thema10aEosinophilic Lung Diseases /cEdited by David J. Jackson, Michael E. Wechsler. 1aSheffield :bEuropean Respiratory Society Journals Ltd,c2022. atext2rdacontent acomputer2rdamedia aonline resource2rdacarrier a02b85.00cUSDd00eThis price includes a tax elementhZ 85.00 0.00 85.00 0.00jGBkxxkmTEDITOR2onix-pt b20220101cIP 20211202jGBkxxk2UK-WkNB0 aERS Monograph,x2312-5098 ;v95 aElectronic book text. Text (eye-readable).0 aAn introduction to eosinophils and their biology-- Differential diagnosis of pulmonary eosinophilia-- Biomarkers of eosinophilic inflammation-- Imaging-- Eosinophilic asthma-- Eosinophilic COPD-- Allergic fungal diseases in the upper and lower airways-- Eosinophilic pneumonias-- Hypereosinophilic syndromes and lung involvement-- Eosinophilic granulomatosis with polyangiitis-- Eosinophils and airway nerves in asthma-- Respiratory viruses and eosinophilic airway inflammation-- Eosinophils as potential mediators of autoimmunity-- Safety of eosinophil depletion-- Future prospects of translational and clinical eosinophil research. aDocument aThis Monograph will ensure the practicing clinician is better equipped to recognise and treat patients with eosinophilia, as well as appreciate the advances coming in the near future.bA great deal of knowledge about eosinophilic lung diseases has been gained in the last few years, but unanswered questions concerning eosinophil biology still remain. It is in this context that this Monograph was developed. Broad in scope, the book bases its approach to the management of eosinophilic lung diseases on a fundamental understanding of eosinophil biology in health and disease. State-of-the-art reviews written by world-leading authorities and up-and-coming stars in the field take the reader on a journey through the different eosinophilic lung diseases. This Monograph will ensure the practicing clinician is better equipped to recognise and treat patients with eosinophilia, as well as appreciate the advances coming in the near future.0 aDavid J. Jackson is an Associate Professor of Respiratory Medicine at King's College London (London, UK) and Clinical Director of Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust (London, UK), a regional unit for severe asthma, eosinophilic granulomatosis with polyangiitis and other eosinophilic lung diseases. Michael E. Wechsler is Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health (NJH) in Denver (CO, USA), Director of the NJH/Cohen Family Asthma Institute (Denver) and Associate Vice President for Innovation and Industry Relations at NJH. 7aRespiratory medicine.2bicssc 7aHealth and Wellbeing.2ukslc 7aRespiratory medicine.2thema1 aJackson, David J.,eeditor.1 aWechsler, Michael E.,eeditor.4 uhttp://books.ersjournals.comx01zPublisher's corporate website4 uhttp://ersbookshop.comx01zPublisher's corporate website